Yahoo
Argus

Argus

•

Oct 28, 2026

MEDP: Raising target price to $741.00

Symbols

MEDP

Sector(s)

Healthcare

Rating

Earnings Estimate

Current Price

$648.14

Price Target

Summary

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms.

Upgrade to begin using premium research reports and get so much more.

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level

Upgrade
Mobilize your Website
View Site in Mobile | Classic
Share by: